Skinny-label ruling will ‘decimate’ Hatch-Waxman, Fed Circuit told

05-01-2021

Rory O'Neill

Skinny-label ruling will ‘decimate’ Hatch-Waxman, Fed Circuit told

Bill Perry / Shutterstock.com

One of the architects of the Hatch-Waxman Act has urged judges to reverse a decision which he says nullifies a key provision of the generic drug legislation.


Hatch-Waxman Act, skinny label, generics, Federal Circuit, Apotex, Mylan, GSK, Teva, Coreg

LSIPR